Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Primary pulmonary hypertension].

U G Svendsen1, C B Andersen, J Aldershvile

  • 1H:S Rigshospitalet, Hjertecentret.

Ugeskrift for Laeger
|March 3, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrence of sarcoid granulomas in lung transplant recipients is common and does not affect overall survival.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2014
Same author

The boson peak of amyloid fibrils: probing the softness of protein aggregates by inelastic neutron scattering.

The journal of physical chemistry. B·2014
Same author

Treatment of intractable interstitial lung injury with alemtuzumab after lung transplantation.

Transplantation proceedings·2011
Same author

Mutation in APOA1 predicts increased risk of ischaemic heart disease and total mortality without low HDL cholesterol levels.

Journal of internal medicine·2011
Same author

Complement factor H deficiency and endocapillary glomerulonephritis due to paternal isodisomy and a novel factor H mutation.

Genes and immunity·2011
Same author

Mutation analysis and evaluation of the cardiac localization of TMEM43 in arrhythmogenic right ventricular cardiomyopathy.

Clinical genetics·2011
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles

Primary pulmonary hypertension (PPH) is a rare, incurable condition causing high blood pressure in lung arteries. Current treatments offer limited success, with transplantation being the only option for severe cases.

Area of Science:

  • Cardiology
  • Pulmonology
  • Medical Research

Context:

  • Primary pulmonary hypertension (PPH) is a progressive, incurable disease characterized by elevated pulmonary artery pressure without a known cause.
  • The incidence in Western Europe is 1-2 per million, with 5-10 new cases annually in Denmark.
  • Diagnosis involves excluding secondary causes of pulmonary hypertension.

Purpose:

  • To outline the definition, diagnosis, and current treatment strategies for Primary Pulmonary Hypertension (PPH).
  • To discuss the limited efficacy of current medical therapies and the role of lung transplantation.
  • To highlight the challenges in managing progressive PPH.

Summary:

  • PPH treatment involves vasodilators (calcium-antagonists, Epoprostenol) and anticoagulants, with diuretics, digoxin, and oxygen as second-line options.

Related Experiment Videos

  • Lung or heart-lung transplantation is the sole curative option for advanced PPH in Denmark.
  • Survival rates post-transplantation for PPH are lower compared to other transplant recipients.

    • Impact:

    • This information is crucial for clinicians managing PPH patients, guiding treatment decisions and patient counseling.
    • Highlights the need for improved therapeutic strategies and better outcomes for PPH.
    • Emphasizes the critical role of early diagnosis and management in improving patient prognosis.